STEPAN COMPANY Proceeds from Other Debt
STEPAN COMPANY (SCL) reported Proceeds from Other Debt of $75.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromOtherDebt · last filed 2026-08-05
- STEPAN COMPANY proceeds from other debt for the quarter ending 2025-12-31 was $0.00.
- STEPAN COMPANY proceeds from other debt for the quarter ending 2025-09-30 was $0.00.
- STEPAN COMPANY proceeds from other debt for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- STEPAN COMPANY proceeds from other debt for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- STEPAN COMPANY proceeds from other debt for fiscal 2025 was $75.00M.
- STEPAN COMPANY proceeds from other debt for fiscal 2022 was $75.00M, a 62.50% decline from fiscal 2021.
- STEPAN COMPANY proceeds from other debt for fiscal 2021 was $200.00M.
| Period end | Proceeds from Other Debt 3 month | Proceeds from Other Debt 6 month | Proceeds from Other Debt 9 month | Proceeds from Other Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $75.00M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $75.00M 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | $75.00M 10-Q · filed 2026-08-05 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-05 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $75.00M 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $75.00M 10-Q · filed 2023-11-02 | $175.00M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $75.00M 10-Q · filed 2023-08-03 | $175.00M derived: sum of 3 quarters · filed 2024-02-29 | $225.00M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $75.00M 10-Q · filed 2023-05-04 | $175.00M derived: sum of 2 quarters · filed 2024-02-29 | $225.00M derived: sum of 3 quarters · filed 2024-02-29 | |
| 2021-12-31 | $100.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $150.00M derived: sum of 2 quarters · filed 2024-02-29 | $200.00M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $100.00M 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $50.00M 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |